BR112022017192A2 - Variantes de transglutaminase - Google Patents
Variantes de transglutaminaseInfo
- Publication number
- BR112022017192A2 BR112022017192A2 BR112022017192A BR112022017192A BR112022017192A2 BR 112022017192 A2 BR112022017192 A2 BR 112022017192A2 BR 112022017192 A BR112022017192 A BR 112022017192A BR 112022017192 A BR112022017192 A BR 112022017192A BR 112022017192 A2 BR112022017192 A2 BR 112022017192A2
- Authority
- BR
- Brazil
- Prior art keywords
- variants
- transglutaminase
- transglutaminase variants
- preservatives
- applications
- Prior art date
Links
- 108060008539 Transglutaminase Proteins 0.000 title abstract 3
- 102000003601 transglutaminase Human genes 0.000 title abstract 3
- 239000003139 biocide Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000009145 protein modification Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00041—Use of virus, viral particle or viral elements as a vector
- C12N2795/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/02—Aminoacyltransferases (2.3.2)
- C12Y203/02013—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Birds (AREA)
- Environmental Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062988918P | 2020-03-13 | 2020-03-13 | |
| PCT/US2021/021766 WO2021183680A1 (en) | 2020-03-13 | 2021-03-10 | Transglutaminase variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022017192A2 true BR112022017192A2 (pt) | 2022-10-18 |
Family
ID=77671938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022017192A BR112022017192A2 (pt) | 2020-03-13 | 2021-03-10 | Variantes de transglutaminase |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230167420A1 (https=) |
| EP (1) | EP4118194A4 (https=) |
| JP (1) | JP2023518714A (https=) |
| KR (1) | KR20220153047A (https=) |
| CN (1) | CN115298306A (https=) |
| BR (1) | BR112022017192A2 (https=) |
| CA (1) | CA3172844A1 (https=) |
| MX (1) | MX2022011077A (https=) |
| WO (1) | WO2021183680A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250304927A1 (en) | 2022-05-20 | 2025-10-02 | Curie Co. Inc. | Pro-peptide variants for modulating activity of transglutaminases |
| CN115487345B (zh) * | 2022-08-22 | 2024-03-12 | 天津大学 | 基于丝素蛋白的止血水凝胶和止血海绵及其制备方法和应用 |
| KR20260013477A (ko) | 2023-05-19 | 2026-01-28 | 큐리 컴퍼니 인코포레이티드 | 트랜스글루타미나제 및 그의 용도 |
| CN117643311B (zh) * | 2023-12-01 | 2024-09-27 | 北京舜雷科技有限公司 | 一种组合物、制备方法及应用 |
| CN121610553B (zh) * | 2026-01-30 | 2026-04-17 | 四川友联味业食品有限公司 | 一种鲜味肽提取物复配取代味精的加工工艺 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2090001T3 (es) * | 1994-02-14 | 1998-08-01 | Univ Leiden | Un metodo para seleccionar por la presencia de un defecto genetico asociado con trombosis y/o una pobre respuesta anticoagulante a la proteina c activada. |
| BR0014059B1 (pt) * | 1999-09-30 | 2013-02-05 | processo para produzir transglutaminase. | |
| KR100575394B1 (ko) * | 2000-08-17 | 2006-05-03 | 아지노모토 가부시키가이샤 | 미생물 유래 트랜스글루타미나제의 변이 방법 |
| US20090117640A1 (en) * | 2005-08-18 | 2009-05-07 | Novo Nordisk Health Care Ag | Transglutaminase Variants with Improved Specificity |
| JP2008194004A (ja) * | 2007-02-15 | 2008-08-28 | Ajinomoto Co Inc | 変異体トランスグルタミナーゼ |
| AU2008215422B2 (en) * | 2007-02-15 | 2011-07-14 | Ajinomoto Co., Inc. | Transglutaminase having disulfide bond introduced therein |
| EP2251421B1 (en) * | 2008-02-13 | 2016-11-16 | Amano Enzyme Inc. | Stabilized transglutaminase and process for production thereof |
| CN102341497B (zh) * | 2009-03-06 | 2013-11-06 | 味之素株式会社 | 放线菌来源的耐热性转谷氨酰胺酶 |
| WO2019014118A1 (en) * | 2017-07-09 | 2019-01-17 | Igc Bio, Inc. | PROSS OPTIMIZED ENZYMES |
| CN107739734B (zh) * | 2017-10-26 | 2020-07-07 | 江南大学 | 一种酶活提高的谷氨酰胺转氨酶突变体 |
| EP3706780A4 (en) * | 2017-11-07 | 2021-12-22 | Codexis, Inc. | TRANSGLUTAMINASE VARIANTS |
| BR112020009793A2 (pt) * | 2017-11-30 | 2020-11-03 | Amano Enzyme Inc. | transglutaminase modificada |
| CN113473856B (zh) * | 2019-03-06 | 2024-03-19 | 居里公司 | 防腐剂组合物及其使用方法 |
| MX2023002744A (es) * | 2020-09-08 | 2023-04-03 | Curie Co Inc | Composiciones y metodos de uso de las mismas. |
-
2021
- 2021-03-10 EP EP21768309.3A patent/EP4118194A4/en active Pending
- 2021-03-10 CN CN202180019827.5A patent/CN115298306A/zh active Pending
- 2021-03-10 BR BR112022017192A patent/BR112022017192A2/pt unknown
- 2021-03-10 CA CA3172844A patent/CA3172844A1/en active Pending
- 2021-03-10 US US17/910,952 patent/US20230167420A1/en active Pending
- 2021-03-10 JP JP2022554747A patent/JP2023518714A/ja not_active Withdrawn
- 2021-03-10 WO PCT/US2021/021766 patent/WO2021183680A1/en not_active Ceased
- 2021-03-10 KR KR1020227034975A patent/KR20220153047A/ko active Pending
- 2021-03-10 MX MX2022011077A patent/MX2022011077A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4118194A4 (en) | 2024-08-21 |
| MX2022011077A (es) | 2022-09-23 |
| US20230167420A1 (en) | 2023-06-01 |
| JP2023518714A (ja) | 2023-05-08 |
| EP4118194A1 (en) | 2023-01-18 |
| KR20220153047A (ko) | 2022-11-17 |
| CN115298306A (zh) | 2022-11-04 |
| WO2021183680A1 (en) | 2021-09-16 |
| CA3172844A1 (en) | 2021-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022017192A2 (pt) | Variantes de transglutaminase | |
| BR112022012410A2 (pt) | Degradadores smarca e usos dos mesmos | |
| BR112023000205A2 (pt) | Misturas fungicidas | |
| BR112021019748A2 (pt) | Degradadores de stat e usos dos mesmos | |
| BR112022018678A2 (pt) | Degradadores de mdm2 e usos dos mesmos | |
| BR112019017403A2 (pt) | composições e métodos para o tratamento de câncer | |
| MX2020004578A (es) | Composiciones de casz y metodos de uso. | |
| BR112023023223A2 (pt) | Degradadores de cdk2 e usos dos mesmos | |
| BR112019012796A2 (pt) | proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas | |
| BR112018006237A2 (pt) | proteínas de ligação a pd-1 e métodos de uso das mesmas | |
| EA201890079A1 (ru) | Клеточная система для направленной доставки активного ингредиента | |
| CL2018000107A1 (es) | Moléculas de anticuerpo que se unen a cd79 | |
| BR112019000693A2 (pt) | composições de muc1- car e métodos para uso | |
| BR112021020999A2 (pt) | Polipeptídeos de ligação à clec12a e usos dos mesmos | |
| MX359201B (es) | Polipeptidos que se unen al complemento humano 5 (c5). | |
| CL2017002856A1 (es) | Compuestos de tioéter como inhibidores de la nitrificación | |
| JOP20230239A1 (ar) | أجسام مضادة للنكتين-4 واستخدامتها | |
| CO2022000481A2 (es) | Inhibidores de enzimas | |
| EA201892500A1 (ru) | Применение фракции лигнина в качестве антифитопатогенного агента и содержащие ее антифитопатогенные композиции | |
| CR20220244A (es) | Moléculas de fusión del ecd de siglec-9 y métodos de uso de estas | |
| EA201791716A1 (ru) | Фармацевтический состав | |
| CR20170040A (es) | Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso | |
| BR112018014355A2 (pt) | processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii | |
| MX2021000542A (es) | Apirasas solubilizadas, metodos y usos. | |
| EP4442717A4 (en) | HIGH VISCOSITY AND HIGH RESISTANCE POLYMER GEL |